Anti-Calpain 2 antibody [EPR5977]
- RabMAb
- Recombinant
- KO Validated
- What is this?
0
(1 Review)
|
(11 Publications)
Rabbit Recombinant Monoclonal Calpain 2 antibody. Suitable for WB and reacts with Rat, Human, Mouse samples. Cited in 11 publications.
View Alternative Names
CANPL2, CAPN2, Calpain-2 catalytic subunit, Calcium-activated neutral proteinase 2, Calpain M-type, Calpain large polypeptide L2, Calpain-2 large subunit, Millimolar-calpain, CANP 2, M-calpain
- WB
Collaborator
Western blot - Anti-Calpain 2 antibody [EPR5977] (AB126600)
ab126600 was shown to react with CAPN2 in wild-type MDA-MB-231 (wpxld GFP) cells in Western blot with loss of signal observed in a CAPN2 knockout cell line. Wild-type MDA-MB-231 (wpxld GFP) and CAPN2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab126600 overnight at 4 °C at a 1/5000 dilution. Blots were incubated with goat anti-rabbit HRP secondary antibodies at 0.2 μg/ml before imaging. These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-Calpain 2 antibody [EPR5977] (ab126600)
Predicted band size: 80 kDa
false
- WB
Collaborator
Western blot - Anti-Calpain 2 antibody [EPR5977] (AB126600)
ab126600 was shown to react with CAPN2 in wild-type MDA-MB-231 (wpxld GFP) and HEK293T cells in Western blot with loss of signal observed in a CAPN2 knockout cell lines. Wild-type MDA-MB-231 (wpxld GFP) and HEK293T ab255449 (CAPN2 knockout cell lysate ab257379) and CAPN2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab126600 overnight at 4 °C at a 1/5000 dilution. Blots were incubated with goat anti-rabbit HRP secondary antibodies at 0.2 μg/ml before imaging. These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-Calpain 2 antibody [EPR5977] (ab126600)
Predicted band size: 80 kDa
false
- WB
Lab
Western blot - Anti-Calpain 2 antibody [EPR5977] (AB126600)
Lanes 1-4 : Merged signal (red and green). Green - ab126600 observed at 80 kDa. Red - loading control ab8245 observed at 36 kDa.
ab126600 Anti-Calpain 2 antibody [EPR5977] was shown to specifically react with Calpain 2 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266628 (knockout cell lysate ab257379) was used. Wild-type and Calpain 2 knockout samples were subjected to SDS-PAGE. ab126600 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2. 5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Calpain 2 antibody [EPR5977] (ab126600) at 1/1000 dilution
Lane 1:
Wild-type HEK293T cell lysate at 20 µg
Lane 2:
CAPN2 knockout HEK293T cell lysate at 20 µg
Lane 2:
Western blot - Human CAPN2 (Calpain 2) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-capn2-calpain-2-knockout-hek-293t-cell-line-ab266628'>ab266628</a>)
Lane 3:
A431 cell lysate at 20 µg
Lane 4:
LNCaP cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 80 kDa
Observed band size: 80 kDa
false
- WB
Unknown
Western blot - Anti-Calpain 2 antibody [EPR5977] (AB126600)
All lanes:
Western blot - Anti-Calpain 2 antibody [EPR5977] (ab126600) at 1/1000 dilution
Lane 1:
Rat brain lysates at 20 µg
Lane 2:
Rat kidney lysates at 20 µg
Lane 3:
PC-3 (Human prostate adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 4:
Mouse brain lysates at 20 µg
Lane 5:
Mouse kidney lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 80 kDa
Observed band size: 80 kDa
false
- WB
Unknown
Western blot - Anti-Calpain 2 antibody [EPR5977] (AB126600)
All lanes:
Western blot - Anti-Calpain 2 antibody [EPR5977] (ab126600) at 1/1000 dilution
Lane 1:
PC3 cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
A431 cell lysate at 10 µg
Lane 4:
293T cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 80 kDa
Observed band size: 80 kDa
false
- WB
CiteAb
Western blot - Anti-Calpain 2 antibody [EPR5977] (AB126600)
Calpain 2 western blot using anti-Calpain 2 antibody [EPR5977] ab126600. Publication image and figure legend from Zeng, X., Chen, S., et al., 2017, Oncotarget, PubMed 29069832.
ab126600 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab126600 please see the product overview.
AG/UnAG attenuates calpain system activity in co-cultured myotubes(A) Western blot of μ-calpain, m-calpain, calpain-3, calpastatin and GAPDH in C2C12 myotubes. (B) Quantification of μ-calpain was normalized to GAPDH. Significant differences were detected between CO and any NC groups (#p < 0.001), between CO and CO+AG/UnAG groups (*p < 0.001), by one-way ANOVA followed by Tukey test. (C-E) Quantification of m-calpain, calpain-3 and calpastatin was normalized to GAPDH. No significant differences were detected among the six groups, by one-way ANOVA followed by Tukey test. (F) The levels of μ-calpain mRNA in C2C12 myotubes. mRNA levels were normalized to GAPDH. Significant differences were detected between NC and CO groups (#P = 0.005, P = 0.007; P = 0.007 respectively), between CO and CO+AG groups (*P = 0.01, P = 0.015 respectively), by one-way ANOVA followed by Tukey test. Data are represented as mean ± SD.
false
Related conjugates and formulations (1)
-
Anti-Calpain 2 antibody [EPR5977] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Calpain-2 plays a significant role in cell signaling cytoskeletal remodeling and apoptosis regulation. It does not typically function in isolation but partners with other molecules forming complexes necessary for precise proteolytic activity. This enzyme modulates several cell functions by cleaving substrates like cytoskeletal proteins transcription factors and enzymes which allows cells to respond adaptively to various stimuli.
Pathways
Calpain-2 integrates into important signaling cascades such as the ERK and PI3K/AKT pathways. It influences these pathways by processing specific proteins and modifying their activity thereby affecting cell survival and proliferation. Calpain-2 closely interacts with proteins like phosphatidylinositol-45-bisphosphate 3-kinase (PI3K) and extracellular signal-regulated kinases (ERKs) within these pathways emphasizing its importance in finely-tuning cellular responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Aging cell 24:e14349 PubMed39380368
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of diabetes investigation 15:1365-1376 PubMed39171660
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational neurodegeneration 13:39 PubMed39095921
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2023:3310621 PubMed36703913
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 28:21 PubMed35183103
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 21:124 PubMed33552245
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of advanced research 34:173-186 PubMed35024189
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2020:6829271 PubMed32685099
2020
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology and applied pharmacology 380:114700 PubMed31398423
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:72872-72885 PubMed29069832
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com